Mapping the human T cell repertoire to recurrent driver mutations in MYD88 and EZH2 in lymphoma

Oncogenic “driver” mutations are theoretically attractive targets for the immunotherapy of lymphoid cancers, yet the proportion that can be recognized by T cells remains poorly defined. To address this issue without any confounding effects of the patient's immune system, we assessed T cells fro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Nielsen, Julie S., Chang, Andrew R., Wick, Darin A., Sedgwick, Colin G., Zong, Zusheng, Mungall, Andrew J., Martin, Spencer D., Kinloch, Natalie N., Ott-Langer, Susann, Brumme, Zabrina L., Treon, Steven P., Connors, Joseph M., Gascoyne, Randy D., Webb, John R., Berry, Brian R., Morin, Ryan D., Macpherson, Nicol, Nelson, Brad H.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5543822/
https://ncbi.nlm.nih.gov/pubmed/28811957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1321184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados